why choose us

First received: July 12, 2022

Clinical Trial: Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Human Leucocytes Bank From COVID-19 Cured Patients With a Cellular Immunity Against SARS-CoV-2 :Raw Material for the Preparation of an Anti-SARS-CoV-2 Cellular Immunotherapy

Brief Summary: The SARS-CoV-2 identified in China in January 2020 is the cause of an unprecedented pandemic.The SARS-CoV-2 and each viral variant are responsible of a respiratory infectious disease, which can be asymptomatic.Nevertheless, a part of infected patients will experiment serious forms associated with a high mortality rate.Most serious forms present with lymphopenia and a functional exhaustion of speicifci T lymphocytes.Several studies showed that these quantitative and qualitative lymphocyte abnormalities are…

Read more